Betahistine Tablets
Indicated to mitigate Ménière's disease and formulated to support balance regulation.
Strengths: 8 · 16 · 24mg
Where to Check Availability
Medicine details
- Alternative names
Serc
- Therapeutic class
Antivertigo Agent
- Pharmacological class
Histamine Analogue
- Contraindications
hypersensitivity to betahistine; phaeochromocytoma
- Minor side effects
nausea; dyspepsia; headache
- Moderate side effects
abdominal distension; skin reactions
- Serious side effects
anaphylaxis — requires immediate medical attention
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
BGP Products
- Onset Time
1–2 weeks
- Duration
6–8 hours
- Storage instructions
Store below 25°C, away from light and humidity.
- Drug interactions
antihistamines
- Age restrictions
Not recommended for children.
- Pregnancy and breastfeeding
Pregnancy: Use should be avoided. Breastfeeding: Not recommended.
Precautions and warnings
monitor patients with asthma; use with care in patients with history of peptic ulcer during pregnancy
Patient summary
Indicated to mitigate Ménière's disease and formulated to support balance regulation.
Mechanism of action
Betahistine acts as a partial histamine H1-receptor agonist and H3-receptor antagonist in the central and autonomic nervous systems, improving microcirculation in the inner ear.
Betahistine Tablets
Indicated to mitigate Ménière’s disease and formulated to support balance regulation.
Editorial Notes
- Active ingredient(s): Betahistine
- Listed indication(s): Meniere’s Disease, Vertigo, Tinnitus, Hearing Loss
Usually available as
- 90 tablets - 8 mg1260-8-mg-15046
- 90 tablets - 16 mg1260-16-mg-15041
- 60 tablets - 24 mg1260-24-mg-15050